Nanotechnological interventions in dermatophytosis: from oral to topical, a fresh perspective

10.7241/ourd.20152.58

10.1016/j.fgb.2010.11.010

10.1101/cshperspect.a019802

10.3389/fmicb.2015.00202

10.1186/s12895-018-0073-1

10.1128/EC.00100-08

10.1007/s11046-016-0082-8

10.1017/S0022172400053663

10.1016/j.jaad.2013.08.031

10.1080/13693780601070107

10.1111/myc.12307

10.1093/mmy/myv057

10.1007/s11046-013-9637-0

10.1007/s11046-009-9260-2

Duran-Valle MT, 2016, Rev Iberoam Micol, 33, 126, 10.1016/j.riam.2015.01.002

10.1016/S0190-9622(08)81263-7

10.4103/0019-5154.82476

10.1007/s11046-008-9104-5

10.1111/j.1365-2230.1993.tb02176.x

10.1016/S0190-9622(09)80300-9

10.4103/CDR.CDR_39_17

Naglot ASD, 2015, Int J Curr Microbiol Appl Sci, 4, 111

Verma S, 2017, Indian J Dermatol, 62, 227, 10.4103/ijd.IJD_206_17

10.4103/2229-5178.178100

Sahni K, 2018, Indian Dermatol Online J, 9, 149, 10.4103/idoj.IDOJ_281_17

10.1001/jamadermatol.2013.1721

10.1111/j.1365-2230.1989.tb00908.x

10.1016/S0190-9622(88)70008-0

10.1111/bjd.13441

10.1111/j.1365-2133.1992.tb00001.x

El-Gohary M, 2014, Cochrane Database Syst Rev, 8, Cd009992

10.4103/2229-5178.131079

10.2310/7750.2008.06009

Stein Gold LF, 2013, J Drugs Dermatol, 12, 911

Stein Gold LF, 2015, J Drugs Dermatol, 14, 1138

Vlahovic TC, 2016, J Drugs Dermatol, 15, s56

10.1517/17425255.4.7.999

10.4103/0019-5154.119955

10.4103/0253-7613.121378

10.1177/0897190016660487

10.1007/s11046-016-0045-0

10.4103/0019-5154.91823

Polak AM, 1992, Dermatol, 17, 8

10.1159/000247612

10.1159/000247613

10.4103/2229-5178.178099

10.1001/archderm.1972.01620120032006

Reynolds JEF, 1982, Martindale: the extra pharmacopoeia, 28

10.1111/j.1365-2133.1997.tb02144.x

10.1001/archderm.1989.01670230079013

10.4103/idoj.IDOJ_169_17

10.1111/j.1365-4362.1989.tb02491.x

Artis W, 1985, Med Educ Serv Oxford, 61

10.1128/AAC.24.6.876

Cauwenbergh G. Skin mycoses: effects of ketoconazole and itraconazole in relation to drug distribution in the skin[Thesis]. Belgium: Catholic University Leuven; 1988.

10.1093/clinids/2.4.592

Rausch L, 1984, Cutis, 34, 470

10.1016/S0190-9622(08)80856-0

Jones H. Ketoconazole today: a review of clinical experience. Germany: ADIS Press; 1987. p. 99.

10.1016/0190-9622(90)70288-S

10.1016/0190-9622(90)70253-E

10.1093/clinids/9.Supplement_1.S119

Cauwenbergh G, De Doncker P. The clinical use of itraconazole in superficial and deep mycoses, in recent trends in the discovery, development and evaluation of antifungal agents. Barcelona: JR Prous Science Publishers; 1987. p. 273–284.

10.1093/clinids/9.Supplement_1.S104

10.1093/clinids/12.Supplement_3.S318

10.1159/000017881

De Cuyper C, 1992, Int J Dermatol, 31, 17

Naeyaert J, 1987, Recent trends in the discovery, development and evaluation of antifungal agents, 157

Andrews MD, 2008, AM FAM Physician, 77, 1415

Ely J, 2014, Am Fam Physician, 90, 702

Hainer BL, 2003, AM FAM Physician, 67, 101

10.3389/fmed.2016.00011

10.1016/B978-0-12-811079-9.00019-7

10.1590/S0365-05962010000500009

10.1128/JCM.42.7.2977-2979.2004

10.4103/ijdvl.IJDVL_526_17

10.4103/ijdvl.IJDVL_717_18

10.1111/myc.12503

10.4103/ijdvl.IJDVL_645_17

10.1128/AAC.00115-17

10.1111/myc.12772

10.1128/AAC.02522-17

10.1021/ci100403b

10.1155/2012/713687

10.1002/jbt.2570040405

Rosenberger A, 1998, Dermatol, 49, 492

Myers R. Antifungal agents, in immunizing and antimicrobial agents. Germany: Springer; 2006. p. 01–6.

10.1007/s11046-008-9110-7

10.3109/09546639009089029

Haneke E, 1992, Int J Dermatol, 31, 3

Fischbein A, 1992, Int J Dermatol, 31, 12

Alcantra R, 1988, Adv Ther, 5, 326

Greer D, 1993, J Eur Acad Dermatol Venereol, 2, S26

10.1158/1078-0432.CCR-07-1441

10.1016/j.ijpharm.2017.03.019

10.3109/08982104.2015.1067892

10.2147/IJN.S96243

Beg S, 2016, Liposomal delivery systems: advances and challenges, 132

10.3389/fphar.2015.00286

10.1016/S0168-3659(00)00339-4

Knight CG. Liposomes, from physical structure to therapeutic applications, ed. Knight CG. New York: Elsevier/North-Holland Biomedical Press; 1981. p. 497.

10.2147/IJN.S68861

10.1073/pnas.78.3.1873

Forssen EA, 1983, Cancer Res, 43, 546

10.1016/j.colsurfb.2014.09.029

Fathalla D, 2015, Clin Exp Ophthalmol, 6, 1

10.1016/j.cis.2015.02.002

10.1042/BSR20090104

10.3109/02652049009040470

10.1208/ps050428

10.2174/15672018113106660064

10.3109/21691401.2013.769446

10.1211/0022357011777800

10.3390/molecules17055972

10.2174/1567201810666140109113830

Agarwal R, 2002, Pharm Technol, 26, 48

Verma A, 2010, Int J Pharm Biol Sci, 1, 1

10.25258/ijddt.v1i1.8834

Mitkari B, 2010, Indian J Pharm Educ Res, 44, 324

10.1007/978-3-642-48391-2_26

10.2147/IJN.S33048

10.2174/1874126600701010036

Shilakari G, 2013, Int J Pharm Sci Rev Res, 21, 77

10.1016/0005-2736(92)90154-E

10.1016/j.drudis.2012.06.013

10.1016/j.ijpharm.2006.05.027

Cevc G, 2003, Modified-release drug delivery technology, 533

10.1016/j.ijpharm.2012.08.015

10.1016/j.colsurfb.2014.05.030

10.3109/08982104.2013.871025

10.2147/IJN.S57314

10.1016/S0168-3659(99)00222-9

10.4103/0110-5558.72415

10.1166/jbn.2010.1152

10.2174/156720106777731091

10.1016/j.nano.2011.10.006

10.1016/j.addr.2009.11.018

10.3109/08982100903544144

10.1016/j.fitote.2010.05.001

10.1016/0378-5173(93)90364-L

10.1007/s11095-015-1836-6

10.1080/08982104.2016.1239636

10.1016/j.jsps.2011.10.001

Bhalaria M, 2009, Indian J Exp Biol, 47, 368

10.1186/1745-6673-3-26

10.1208/s12249-012-9754-y

10.1016/S0378-5173(98)00169-0

10.1159/000089138

10.2174/1567201813666160328113522

Florence A, 1993, Int J Pharmtech Res, 2, 157

10.1016/j.jconrel.2014.04.015

10.1111/j.2042-7158.1985.tb05051.x

10.1111/j.2042-7158.1985.tb04990.x

10.1111/j.1467-2494.1979.tb00224.x

10.3109/10611860903079454

10.3109/03639049309062986

Niemiec S, 1994, STP Pharm Sci, 4, 145

10.1016/0168-3659(94)90039-6

Van Hal D, 1996, STP Pharm Sci, 6, 72

Junginger H, 1991, Cosmet Toiletries, 106, 45

10.1111/j.1439-0507.2006.01221.x

10.4103/2230-973X.107002

10.3390/pharmaceutics7040438

10.1016/S0169-409X(02)00118-7

Müller R, 1998, Eurocosmetics, 7, 19

Muller R, 1998, Pharm Ztg, 143, 11

10.1016/j.ijpharm.2006.08.007

10.1016/S0939-6411(00)00087-4

Wissing S, 2001, Pharmazie, 56, 783

10.1016/j.ijpharm.2009.01.014

10.1016/j.ejps.2013.03.013

Chen Y-C, 2012, Int J Nanomed, 7, 4409

10.1208/s12249-009-9199-0

10.1166/jbn.2013.1569

10.1080/10717544.2017.1413444

10.3109/10837450.2011.598161

10.1080/02652040500162436

10.1016/j.ijpharm.2004.02.032

10.1016/j.colsurfb.2016.07.046

10.1016/j.ijpharm.2015.12.061

10.1016/j.ijpharm.2016.12.010

10.1208/s12249-018-1148-3

10.1615/CritRevTherDrugCarrierSyst.2017019047

10.1016/j.ejpb.2013.08.013

10.3109/1061186X.2012.716845

10.1007/s13346-015-0263-x

10.1016/j.chemphyslip.2012.01.006

10.1111/ijd.13902

10.2147/IJN.S134526

10.1002/1521-3765(20020104)8:1<28::AID-CHEM28>3.0.CO;2-B

10.1021/nn4044047

10.1021/sc4000362

10.2147/IJN.S152010

10.1007/s10123-003-0130-3

Fatemeh N, 2011, 2011 International Conference on Bioscience, Biochemistry and Bioinformatics IPCBEE

10.1515/ntrev-2015-0010

Firthouse PM, 2011, Int J Pharmtech Res, 3, 1019

Ataei S, 2011, J Pharm Sci, 1, 50

Brillowska-Dabrowska AH, 2006, Pcr diagnostics of dermatophytes and other pathogenic fungi

Pier AC. Broad spectrum dermatophyte vaccine. Patent US, Editor. Unites States. 1994.

Gray NM, Methods ad compositions of (+) ketoconazole for treating fungal yeast and dermatophyte infections

Gray NM, 2000, Methods ad compositions of (-) ketoconazole for treating fungal yeast and dermatophyte infections

Jules Remenar MM, Peterson ML, Morissette SL, et al. Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods. Publication USPA, Editor. Lexington (MA): Transform Pharmaceuticals, Inc. 2004.

Lynne B, 1989, Method of treating Tinea pedis and related dermatophytic infections

Baker JR, 2009, Methods of treating fungal, yeast and mold infections

Erik Fred Godefroi CAMVE, 1969, Composition and method for combating fungus with imidazole carboxylates

Maibach HI, 2005, Topical administration of basic antifungal compositions to treat fungal infections of the nails